James B. Young, MD

Evolution of heart failure management: Miles to go

Despite progress, too many patients still suffer, too many die too young, and the costs are still too great.

Author:: Christine S. Moravec, PhD; Michael G. McKee; James B. Young, MD; Betul Hatipoglu; Leopoldo Pozuelo; Leslie Cho; Gordon Blackburn; Francois Bethoux; Mary Rensel; Katherine Hoercher, RN; Javier Provencio; Marc S. Penn, MD, PhD

Author:: Denton A. Cooley, MD; John J. Fung, MD, PhD; James B. Young, MD; Thomas E. Starzl, MD, PhD; Mark Siegler, MD; Pauline W. Chen, MD

Dr. Thomas Lansdale’s provocative essay “A medical center is not a hospital” (September 2008) is, in many respects, on target.

Author:: James B. Young, MD; Natalie G. Correia, DO; Gary S. Francis, MD; Alan Maisel, MD; Franklin Michota, MD, FACP

To treat heart failure effectively you need a team and you need a plan. In short, you need a program.

The discovery that inflammation contributes to heart failure may lead to new therapies for this disease.

In this landmark trial, ACE inhibitors showed benefit beyond lowering blood pressure.

Heart failure is going to be every physician's problem, regardless of specialty.

The idea of using beta blockers to treat heart failure seems counterintuitive. But carvedilol is changing that thinking.